Drug Shortage Report for TELMISARTAN
Report ID | 109445 |
Drug Identification Number | 02388944 |
Brand name | TELMISARTAN |
Common or Proper name | TELMISARTAN |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | TELMISARTAN |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-26 |
Estimated end date | 2020-04-30 |
Actual end date | 2020-05-11 |
Shortage status | Resolved |
Updated date | 2020-05-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-26 | English | Compare |
v2 | 2020-03-26 | French | Compare |
v3 | 2020-03-27 | English | Compare |
v4 | 2020-04-08 | English | Compare |
v5 | 2020-04-08 | French | Compare |
v6 | 2020-05-11 | English | Compare |
v7 | 2020-05-11 | French | Compare |
v8 | 2020-05-12 | English | Compare |
Showing 1 to 8 of 8